Alkermes Plc Quick Ratio Over Time
ALKS Stock | USD 23.85 0.09 0.38% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Alkermes Plc Performance and Alkermes Plc Correlation. Alkermes |
Is Alkermes Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alkermes Plc. If investors know Alkermes will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alkermes Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 3.06 | Revenue Per Share 10.007 | Quarterly Revenue Growth 0.239 | Return On Assets 0.1281 | Return On Equity 0.4622 |
The market value of Alkermes Plc is measured differently than its book value, which is the value of Alkermes that is recorded on the company's balance sheet. Investors also form their own opinion of Alkermes Plc's value that differs from its market value or its book value, called intrinsic value, which is Alkermes Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alkermes Plc's market value can be influenced by many factors that don't directly affect Alkermes Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alkermes Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alkermes Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alkermes Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Quick Ratio Analysis
Compare Alkermes Plc and related stocks such as Intracellular Th, Ironwood Pharmaceuticals, and Deciphera Pharmaceuticals Quick Ratio Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ITCI | 6.8481 | 6.8481 | 6.8481 | 5.4854 | 12.2854 | 75.8729 | 36.4777 | 32.6773 | 9.5741 | 6.184 | 18.1317 | 8.1057 | 8.0145 | 4.9533 | 4.71 |
IRWD | 3.9238 | 2.5281 | 3.0892 | 4.8932 | 4.5287 | 6.4593 | 4.0609 | 4.5977 | 2.1261 | 7.1897 | 14.8233 | 4.5404 | 30.2316 | 0.8014 | 0.76 |
DCPH | 8.4515 | 8.4515 | 8.4515 | 8.4515 | 8.4515 | 8.4515 | 12.6094 | 14.2421 | 12.8074 | 9.6535 | 8.0842 | 3.1644 | 4.012 | 3.3724 | 3.2 |
PCRX | 0.8798 | 2.4526 | 5.4994 | 0.7113 | 2.1404 | 1.8909 | 4.517 | 6.1014 | 6.9477 | 3.1529 | 2.2686 | 1.4444 | 2.6192 | 3.9446 | 2.34 |
ANIP | 3.4738 | 7.9175 | 3.2844 | 6.6755 | 14.081 | 15.0235 | 2.2931 | 2.2925 | 0.6515 | 2.1801 | 1.3194 | 2.614 | 2.1487 | 2.6341 | 2.5 |
RDY | 0.6387 | 1.3567 | 1.0079 | 1.867 | 1.9428 | 1.9376 | 0.9595 | 0.9492 | 1.1395 | 1.2016 | 1.0673 | 1.1694 | 1.6243 | 1.87 | 1.62 |
COLL | 2.8843 | 2.8843 | 2.8843 | 2.8843 | 0.1569 | 16.5997 | 6.7754 | 4.0862 | 1.1979 | 1.2316 | 1.3462 | 1.2685 | 1.3209 | 1.0702 | 1.02 |
EGRX | 0.3902 | 0.3902 | 1.0863 | 2.4621 | 3.0748 | 3.0748 | 2.3627 | 3.5618 | 3.6607 | 4.0641 | 4.0507 | 1.9333 | 1.1501 | 1.04 | 2.02 |
PAHC | 1.2918 | 1.2159 | 1.0962 | 1.1178 | 1.2603 | 1.4483 | 1.5711 | 1.5005 | 1.56 | 1.3856 | 1.4628 | 1.3508 | 1.3907 | 1.25 | 0.89 |
PBH | 1.3149 | 1.2397 | 0.9178 | 1.107 | 1.1024 | 1.148 | 1.1024 | 1.4077 | 1.3886 | 1.6365 | 1.2033 | 1.161 | 1.4031 | 1.61 | 1.42 |
NBIX | 3.0732 | 2.7809 | 11.9585 | 12.4594 | 12.3729 | 14.7459 | 10.1055 | 10.0514 | 8.0146 | 1.41 | 8.429 | 3.6485 | 2.4908 | 2.2463 | 2.13 |
DVAX | 6.9791 | 4.5368 | 6.6338 | 11.7961 | 6.0841 | 6.8619 | 4.1304 | 10.3645 | 3.924 | 3.0151 | 2.4247 | 1.2181 | 5.1435 | 12.6511 | 6.67 |
AMPH | 1.473 | 1.473 | 1.473 | 1.2324 | 1.4769 | 1.6818 | 1.6444 | 1.641 | 1.3234 | 1.4559 | 1.533 | 2.0769 | 2.7908 | 1.66 | 1.34 |
EOLS | 0.3414 | 0.3414 | 0.3414 | 0.3414 | 0.3414 | 0.3414 | 0.3414 | 0.3414 | 17.6577 | 5.7475 | 0.6504 | 2.7906 | 1.642 | 1.9334 | 1.84 |
Alkermes Plc and related stocks such as Intracellular Th, Ironwood Pharmaceuticals, and Deciphera Pharmaceuticals Quick Ratio description
A measure of a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as (current assets - inventories) divided by current liabilities.My Equities
My Current Equities and Potential Positions
Alkermes Plc | ALKS |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Location | Ireland |
Exchange | NASDAQ Exchange |
USD 23.85
Check out Alkermes Plc Performance and Alkermes Plc Correlation. For more information on how to buy Alkermes Stock please use our How to Invest in Alkermes Plc guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Alkermes Stock analysis
When running Alkermes Plc's price analysis, check to measure Alkermes Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alkermes Plc is operating at the current time. Most of Alkermes Plc's value examination focuses on studying past and present price action to predict the probability of Alkermes Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alkermes Plc's price. Additionally, you may evaluate how the addition of Alkermes Plc to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Alkermes Plc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.